Newron Pharmaceuticals SpA

FSX:NP5.DE

9 (EUR) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q42009 Q22008 Q42008 Q22007 Q42007 Q22006 Q42006 Q22005 Q42005 Q22004 Q4
Revenue 48.1693.4073.5635.4943.2642.833.0912.6712.7492.5094.8062.2322.0172.0081.74111.6872.8183.9080.4011.9790.1571.41.3872.1524.4624.4620.140.140.4030.4031.2711.2711.9671.9672.0122.0120.5960.5960.29800
Cost of Revenue 48.16900000000000000000000000.0670.0140.014000000000000000
Gross Profit 03.4073.5635.4943.2642.833.0912.6712.7492.5094.8062.2322.0172.0081.74111.6872.8183.9080.4011.9790.1571.41.3872.0854.4484.4480.140.140.4030.4031.2711.2711.9671.9672.0122.0120.5960.5960.29800
Gross Profit Ratio 011111111111111111111110.9690.9970.997111111111111100
Reseach & Development Expenses 7.1826.4537.5175.6856.7255.3243.9766.7838.5537.7779.23813.2218.1487.6716.4716.9129.9649.2749.0097.5638.016.4577.474.4371.7671.7671.9111.9117.9617.9619.2729.2726.4416.4414.0994.0995.7445.7442.8725.32.65
General & Administrative Expenses 04.5613.3653.9913.3283.8223.5383.7033.7224.3383.895.8864.2064.2353.8354.2414.5384.2864.1533.9733.1233.4472.9933.6572.0762.0763.4493.4493.2263.2264.2344.2344.6284.6284.7244.7243.313.311.6552.2721.136
Selling & Marketing Expenses 00.0580.0270.0530.0160.0650.0090.0290.0060.3250.1940.440.2350.1710.4110.2970.370.1430.0120.0410.0060.0470.0040.0110.0310.0310.0260.0260.0370.0370.0430.0430.0580.0580.0660.06600000
SG&A 6.9044.6373.4194.1153.4323.9593.3584.0363.6274.8443.9776.524.5774.5914.5464.9535.2954.7184.3794.23.3043.6443.1693.8262.1072.1073.4753.4753.2623.2624.2774.2774.6864.6864.7894.78912.445-5.826-2.913-5.333-2.667
Other Expenses 00-0.050000000000000000000-3.882-1.9767.288-3.4147.38-7.3900000000-0.1640000
Operating Expenses 14.08511.0910.88610.44510.0979.5787.31610.46610.66412.03410.52616.2939.5279.5938.71710.1319.25712.77918.5458.9416.3536.0346.7574.55811.1610.468.767-2.00511.22311.22313.54913.54911.12611.1268.8888.88818.025-0.082-0.041-0.034-0.017
Operating Income 33.987-7.683-7.323-4.306-6.849-6.453-4.469-7.888-8.099-9.967-6.459-14.44-7.383-7.595-6.432.334-6.448-8.877-10.832-6.843-4.325-4.765-5.37-2.406-1.457-1.241-3.267-3.216-10.804-10.837-12.381-12.176-10.141-8.178-8.137-5.544-8.376-8.376-4.188-7.538-3.769
Operating Income Ratio 0.706-2.255-2.055-0.784-2.098-2.28-1.446-2.953-2.946-3.972-1.344-6.47-3.66-3.782-3.6930.2-2.288-2.271-27.012-3.458-27.548-3.404-3.872-1.118-0.326-0.278-23.332-22.968-26.808-26.89-9.741-9.579-5.157-4.159-4.044-2.755-14.065-14.065-14.06500
Total Other Income Expenses Net -2.929-1.861-1.938-2.633-1.988-2.182-1.353-1.174-1.022-0.530.3370.4-0.0810.04-0.455-0.75-0.0130.134-0.515-0.0680.3180.1740.099-0.0360.208-0.0080.048-0.003-0.03300.20501.96302.59300.1760.1760.0880.0790.039
Income Before Tax 31.058-9.544-9.261-6.939-8.837-8.635-5.822-9.062-9.121-10.497-6.122-14.04-7.464-7.555-6.8851.584-6.461-8.743-18.072-6.911-6.132-4.591-5.271-2.442-1.249-1.249-3.219-3.219-10.837-10.837-12.176-12.176-8.178-8.178-5.544-5.544-8.201-8.201-4.1-7.46-3.73
Income Before Tax Ratio 0.645-2.801-2.599-1.263-2.707-3.051-1.884-3.393-3.318-4.184-1.274-6.29-3.701-3.762-3.9550.136-2.293-2.237-45.067-3.492-39.057-3.279-3.8-1.135-0.28-0.28-22.989-22.989-26.89-26.89-9.579-9.579-4.159-4.159-2.755-2.755-13.771-13.771-13.77100
Income Tax Expense 5.5590.0130.0130.0110.020.0010.0160.0011.3740.0060.0390.0060.010.0260.0450.0260.0220.0112.1790.0120.6330.0050.6190.004-0.061-0.0610.0040.004-0.564-0.564-0.435-0.4350.0040.0040.0010.001-0.176-0.176-0.088-0.079-0.039
Net Income 25.498-9.557-9.274-6.95-8.857-8.636-5.838-9.063-10.495-10.503-6.161-14.046-7.454-7.581-6.841.558-6.483-8.754-15.893-6.923-5.499-4.596-4.652-2.446-1.188-1.188-3.223-3.223-10.273-10.273-11.741-11.741-8.182-8.182-5.545-5.545-8.376-8.025-4.013-7.381-3.691
Net Income Ratio 0.529-2.805-2.603-1.265-2.714-3.052-1.889-3.393-3.818-4.186-1.282-6.293-3.696-3.775-3.9290.133-2.301-2.24-39.633-3.498-35.025-3.283-3.354-1.137-0.266-0.266-23.018-23.018-25.49-25.49-9.237-9.237-4.161-4.161-2.756-2.756-14.065-13.476-13.47600
EPS 1.28-0.51-0.52-0.39-0.5-0.48-0.33-0.51-0.59-0.59-0.35-0.79-0.42-0.42-0.410.09-0.41-0.64-1.13-0.52-0.42-0.37-0.4-0.21-0.144-0.146-0.45-0.44-1.55-1.56-1.94-1.92-1.36-1.38-0.94-0.96-2.21-2.12-1.06-2.62-1.31
EPS Diluted 1.28-0.51-0.52-0.39-0.5-0.48-0.33-0.51-0.59-0.59-0.35-0.79-0.42-0.42-0.410.093-0.41-0.64-1.13-0.52-0.42-0.37-0.4-0.21-0.144-0.146-0.45-0.44-1.55-1.56-1.94-1.92-1.36-1.38-0.94-0.96-2.21-2.12-1.06-2.62-1.31
EBITDA 33.32-7.587-7.288-4.204-6.911-6.354-4.527-7.783-8.136-9.858-6.51-14.337-7.284-7.502-6.4052.357-6.431-8.861-10.778-6.826-4.308-4.749-3.263-2.389-1.425-1.209-3.172-3.172-10.729-10.762-12.119-11.914-10.006-8.043-8.031-5.438-8.526-8.201-4.1-7.46-3.73
EBITDA Ratio 0.692-2.227-2.045-0.765-2.117-2.245-1.465-2.914-2.96-3.929-1.355-6.423-3.611-3.736-3.6790.202-2.282-2.267-26.878-3.449-27.439-3.392-2.353-1.11-0.319-0.271-22.654-22.654-26.623-26.705-9.535-9.373-5.088-4.09-3.991-2.703-14.317-13.771-13.77100